U.S. flag

An official website of the United States government

NIH: Fogarty International Center NIH: Fogarty International Center
Advancing Science for Global Health
Advancing Science for Global Health
Home > Search Current & Recent Grants > Novel Therapeutic Agents from the Bacterial Symbionts of Brazilian Invertebrates Print

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov​.

Novel Therapeutic Agents from the Bacterial Symbionts of Brazilian Invertebrates

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

Biodiversity (ICBG)

Project Information in NIH RePORTER

Novel Therapeutic Agents from the Bacterial Symbionts of Brazilian Invertebrates

Principal Institution

Harvard Medical School; University of São Paulo

Principal Investigator(s) (PI)

Clardy, Jon; Tallarico Pupo, Monica

Project Contact Information

Email: jon_clardy@hms.harvard.edu

Year(s) Awarded

2014-2020

Country

Brazil

Collaborators

University of Wisconsin - Madison
Dana-Farber Cancer Institute
University of São Paulo School of Pharmaceutical Sciences of Ribeirão Preto
University of São Paulo Institute of Physics of São Carlos

NIH Partners

NCCAM, NCI, NIGMS

Project Description

Parallel funding for Brazilian activities is provided by the São Paulo Research Foundation (FAPESP), Brazil. View full details of the FAPESP grant.

Additional funding partner: U.S. National Science Foundation (NSF)

Related World Regions / Countries